TOPAS Advanced Polymers is showcasing its versatile line of cyclic olefin copolymers (COC) for the medical device and diagnostic industry. TOPAS’ unique manufacturing technologies are enabling the development of new COC grades with a range of useful performance capabilities. These include elastomeric materials, advanced compounds, and plastics suited for the next generation of diabetes care devices.
Kneale noted that TOPAS resins are finding increased use in medical devices and diagnostic applications due to the materials’ broad property profile. These biologically-inert materials offer high rigidity and dimensional stability; high purity with low extractables/leachables; excellent biocompatibility, chemical resistance, and moisture barrier; the highest UV transmission of any plastic; and outstanding detail replication including submicron features. These innovative materials also provide glass-like transparency, variable Tg and compatibility with all sterilization methods including steam, and compliance with USP Class VI/ISO 10993 and FDA regulations.
For more information, visit www.topas.com.